Search clinical trials for: Dabigatran clopidogrel

Total 1080 results

Hospital Central San Luis Potosi, Mexico

Unknown

Patent Versus Generic Clopidogrel in Acute Coronary Syndrome

Acute Coronary Syndrome
Boehringer Ingelheim

Completed

Relative Bioavailability and Pharmacodynamics of Dabigatran With Enoxaparin in Healthy Male and Female Volunteers

Healthy
Takeda

Completed

A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.

Healthy

United States
Centre Hospitalier Universitaire de Saint Etienne

Completed

Investigation of Drug-drug Interaction Between Clopidogrel and Fluoxetine (PLATINE)

Healthy

France
Lady Reading Hospital, Pakistan
Pakistan Chest Society, Pakistan

Recruiting

Clopidogrel for the Prevention of Exacerbations in Severe COPD (CLOPEX)

COPD | COPD Exacerbation Acute

Pakistan
Deutsches Herzzentrum Muenchen

Terminated

Abrupt Versus Tapered Interruption of Chronic Clopidogrel Therapy After DES Implantation (ISAR-CAUTION)

Coronary Artery Disease

Germany
Boehringer Ingelheim

Completed

Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE)

Venous Thromboembolism

United States, Spain, Norway, Canada, Belgium, Thailand, Germany, Turkey, Austria, Hungary, Czechia, Taiwan, Israel, Brazil, Denmark, Italy, Lithuania, Russian Federation, Sweden, Switzerland, Ukraine, Mexico, Greece, Argentina, Finland, ...
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Effectiveness of Clopidogrel Resinate in PCI(PRIDE)

Coronary Artery Disease

Korea, Republic of
University of Pecs
Hungarian Academy of Sciences; KRKA

Completed

Comparison of Generic and Original Formulation of Clopidogrel (DOSER-GENERIC)

Coronary Heart Disease | Percutaneous Coronary Intervention
The Third Xiangya Hospital of Central South University

Completed

Study on the Registration of Coronary Heart Disease Patients Undergoing PCI

Coronary Heart Disease

China
Boehringer Ingelheim

Completed

Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)

Stroke | Secondary Prevention

Korea, Republic of, United States, Spain, Canada, Germany, Taiwan, Belgium, Australia, Hong Kong, India, Singapore, Thailand, Greece, Italy, Japan, China, Turkey, Russian Federation, Serbia, Switzerland, Israel, South Africa, Malaysia, Fran... and more
Pfizer

Completed

Apixaban Drug Utilization Study In Stroke Prevention In Atrial Fibrillation (Spaf) (SPAF)

Atrial Fibrillation

Spain
Odense University Hospital

Completed

Early Versus Late DC-cardioversion of Persistent Atrial Fibrillation. Effect on Atrial Remodeling,Inflammatory and Neurohumoral Markers and Recurrence of Atrial Fibrillation

Atrial Fibrillation

Denmark
Janssen Research & Development, LLC

Completed

A Pharmacokinetic Interaction Study Between Odalasvir, Given as a Single Agent or in Combination With Simeprevir, and Dabigatran Etexilate Mesylate in Healthy Participants

Healthy

United States
Boehringer Ingelheim

Completed

Relative Bioavailability of Dabigatran and Digoxin in Healthy Male and Female Volunteers

Healthy
Boehringer Ingelheim
Uppsala University

Completed

RE-DEEM Dose Finding Study for Dabigatran Etexilate in Patients With Acute Coronary Syndrome

Coronary Disease

United States, Belgium, Bulgaria, Canada, Czech Republic, Denmark, Finland, France, Georgia, Germany, Hungary, India, Ireland, Italy, Korea, Republic of, Netherlands, Norway, Poland, Romania, Russian Federation, Spain, Sweden, Ukraine, United Kingdom
Ajou University School of Medicine
Dong-A Pharmaceutical

Completed

Point-of-Care Measurements of Platelet Inhibition After Clopidogrel Loading in Patients With Acute Coronary Syndrome: Comparison of Generic Clopidogrel Bisulfate (Plavitor®) With Original Clopidogrel Bisulfate (Plavix®)

Acute Coronary Syndrome

Korea, Republic of
Huons Co., Ltd.

Unknown

Clinical Trial to Assess the Safety and Pharmacokinetics of RDG-17012 Capsule and Pradaxa® Capsule in Healthy Male Volunteers

Healthy

Korea, Republic of
Boehringer Ingelheim

Completed

Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE) (RE-COVER II)

Thromboembolism

United States, Australia, Brazil, Bulgaria, Canada, China, Czech Republic, Denmark, France, Hungary, India, Israel, Italy, Korea, Republic of, Malaysia, Netherlands, New Zealand, Norway, Philippines, Poland, Russian Federation, Si... and more
Bristol-Myers Squibb

Completed

Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients

Atrial Fibrillation
Bristol-Myers Squibb

Completed

Replication Of An Early Evaluation Of 30-Day Readmissions Among Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran, Rivaroxaban, Apixaban, or Warfarin In The U.S

Atrial Fibrillation
National Cheng-Kung University Hospital
Tainan Municipal Hospital; E-DA Hospital; Ministry of Health and Welfare, Taiwan and other collaborators

Unknown

Comparison of Efficacy and Safety Among Dabigatran, Rivaroxaban, and Apixaban in Non-Valvular Atrial Fibrillation (DARING-AF)

Atrial Fibrillation

Taiwan
Hospital Ana Nery

Terminated

Dabigatran Versus Warfarin After Mitral and/or Aortic Bioprosthesis Replacement and Atrial Fibrillation Postoperatively (DAWA)

Primary Disease

Brazil
University of Alberta

Completed

Dabigatran Treatment Following Transient Ischemic Attack and Minor Stroke (DATAS)

Transient Ischemic Attack | Minor Ischemic Stroke

Canada
University of Pecs

Completed

Prasugrel Versus Clopidogrel to TREAT High Platelet Reactivity (TREAT-HPR)

Acute Coronary Syndrome

Hungary
Sir Run Run Shaw Hospital

Unknown

Effect of Different Anti-platelet Strategies on the Long-term Outcome After Sirolimus Drug-eluting Stent Implantation (EASTS)

Coronary Artery Disease
Boehringer Ingelheim

Completed

Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE (RE-SONATE)

Venous Thromboembolism

United States, Australia, Austria, Belgium, Canada, Czech Republic, Estonia, Germany, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Russian Federation, Singapore, South Africa, Sweden, Switzer... and more
Centre of Postgraduate Medical Education

Unknown

Comparison of Blood Loss Following Total Hip Arthroplasty With the Use of Three Thromboprophylactic Regimes: Dabigatran, Enoxaparin and Rivaroxaban.

Blood Loss | Hip Osteoarthritis

Poland
Vanderbilt University Medical Center
Boehringer Ingelheim

Active, not recruiting

Efficacy of Short Term Dabigatran Etexilate Followed by Aspirin Monotherapy After LAA (Left Atrial Appendage) Device Closure (the DEA-LAA Study). (DEA-LAA)

Atrial Fibrillation | Left Atrial Appendage Thrombosis | Device Related Thrombus | Watchman LAA Closure Device

United States
The University of Hong Kong

Unknown

A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

Hong Kong
Insel Gruppe AG, University Hospital Bern

Completed

Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial (ELAN)

Ischaemic Stroke

Belgium, Ireland, Israel, Germany, India, United Kingdom, Austria, Switzerland, Finland, Norway, Italy, Portugal, Slovakia, Japan, Greece
Medical University of Gdansk
Institute of Cardiology, Warsaw, Poland; Medical University of Silesia; Pomeranian... and other collaborators

Recruiting

Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI (ADONIS-PCI)

Atrial Fibrillation | Acute Coronary Syndrome | Antithrombotic Therapy | Percutaneous Coronary Interventions

Poland
Pfizer

Active, not recruiting

A Study to Learn About the Effects of Medicines That Help in Thinning the Blood in People With Atrial Fibrillation (AF) Between 2016 and 2020 in France (SIFNOS)

Atrial Fibrillation

France
Rabin Medical Center

Unknown

Perfusion Computer Tomography: Imaging and Clinical Validation Following Reperfusion Therapy in Acute Ischaemic Stroke

Ischemic Stroke

Israel
University of Sao Paulo
Boehringer Ingelheim; Federal University of Minas Gerais

Completed

Cognitive Impairment Related to Atrial Fibrillation Prevention Trial (GIRAF)

Atrial Fibrillation

Brazil
St. Antonius Hospital

Completed

Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation (POPular-TAVI)

Myocardial Infarction | Stroke | Bleeding | Aortic Valve Disease

Netherlands, Belgium, Czechia, Luxembourg
University of Sao Paulo General Hospital

Completed

Tooth Extraction in Patients With Atrial Fibrillation in Use of New Oral Anticoagulants

Hemorrhage | Atrial Fibrillation | Periodontal Disease

Brazil
Fundació Institut de Recerca de l'Hospital de la...
Daiichi Sankyo

Recruiting

Real-life Clinical Outcomes of Direct Oral Anticoagulants (MACACOD) (MACACOD)

Atrial Fibrillation | Recurrent Venous Thromboembolism

Spain
Bayer
Janssen Research & Development, LLC

Completed

Study to Gather Information How Often Venous Thromboembolism Occurs in Prostate Cancer Patients in Sweden and How This Condition is Treated With Blood Thinners (PRACTISE)

Venous Thromboembolism (VTE)

Sweden
Creighton University

Completed

The Impact of Grapefruit Juice on the Response to Clopidogrel

Healthy

United States
Korea University Anam Hospital

Completed

Genotyping Influences Outcome of Coronary Artery Stenting (GENIUS)

Myocardial Ischemia | CLOPIDOGREL, POOR METABOLISM of (Disorder)
Universität Münster
photonamic GmbH & Co. KG

Recruiting

Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor (ALA-RDTinGBM)

Glioblastoma

Germany
Khon Kaen University

Completed

Comparative Pharmacodynamics and Pharmacokinetics Study of Generic and Reference Clopidogrel Products

Pharmacodynamics

Thailand
National Taiwan University Hospital

Recruiting

Evaluataion of NOAC Levels in Acute Stroke

Ischemic Stroke | Anticoagulant Adverse Reaction

Taiwan
University of Birmingham
University of Oxford; University Hospital Birmingham NHS Foundation Trust; London... and other collaborators

Recruiting

Preventing Stroke, Premature Death and Cognitive Decline in a Broader Community of Patients With Atrial Fibrillation (DaRe2THINK)

Atrial Fibrillation

United Kingdom
Bayer

Completed

Accessibility to New Drugs Versus SOC in Sweden

Anticoagulation

Sweden
Korea University Guro Hospital

Completed

Drug Interaction Study of Simvastatin and Dabigatran

Healthy

Korea, Republic of
Boehringer Ingelheim

Completed

Medical Need of OAC Reversal

Atrial Fibrillation

Japan
University College, London

Recruiting

OPTIMAS: OPtimal TIMing of Anticoagulation After Acute Ischaemic Stroke : a Randomised Controlled Trial (OPTIMAS)

Atrial Fibrillation | Stroke, Acute

United Kingdom
University of California, San Francisco
Patient-Centered Outcomes Research Institute; Kaiser Permanente

Completed

Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study (ALTERNATIVE)

Venous Thromboembolism | Anticoagulants and Bleeding Disorders

United States

Search clinical trials for: Dabigatran clopidogrel

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations